These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8777681)
1. Factors related to transfusion in very low birthweight infants treated with erythropoietin. Maier RF; Obladen M; Messinger D; Wardrop CA Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F182-6. PubMed ID: 8777681 [TBL] [Abstract][Full Text] [Related]
2. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era. Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976 [TBL] [Abstract][Full Text] [Related]
3. [Recombinant human erythropoietin: analysis of a policy of treatment in an hospital based population of very-low-birthweight infants]. Joriot-Chekaf S; Pierrat V; Desnoulez L; Rakza T; Lequien P; Storme L Arch Pediatr; 2003 Jun; 10(6):499-505. PubMed ID: 12915011 [TBL] [Abstract][Full Text] [Related]
4. Early treatment of premature infants with recombinant human erythropoietin. Messer J; Haddad J; Donato L; Astruc D; Matis J Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820 [TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human erythropoietin on transfusion needs in preterm infants. Yeo CL; Choo S; Ho LY J Paediatr Child Health; 2001 Aug; 37(4):352-8. PubMed ID: 11532054 [TBL] [Abstract][Full Text] [Related]
6. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Ohlsson A; Aher SM Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062 [TBL] [Abstract][Full Text] [Related]
7. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. Maier RF; Obladen M; Kattner E; Natzschka J; Messer J; Regazzoni BM; Speer CP; Fellman V; Grauel EL; Groneck P; Wagner M; Moriette G; Salle BL; Verellen G; Scigalla P J Pediatr; 1998 May; 132(5):866-70. PubMed ID: 9602202 [TBL] [Abstract][Full Text] [Related]
8. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Aher SM; Ohlsson A Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of early erythropoietin use in critically ill, very-low-birthweight premature newborn infants: controlled clinical trial]. Lima-Rogel V; Torres-Montes A; Espinosa Griesse S; Villegas Alvarez C; Hernández-Sierra F; Bissett Mandeville P; Correa González C Sangre (Barc); 1998 Jun; 43(3):191-5. PubMed ID: 9741224 [TBL] [Abstract][Full Text] [Related]
10. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. Carnielli V; Montini G; Da Riol R; Dall'Amico R; Cantarutti F J Pediatr; 1992 Jul; 121(1):98-102. PubMed ID: 1625101 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284 [TBL] [Abstract][Full Text] [Related]
12. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Maier RF; Obladen M; Müller-Hansen I; Kattner E; Merz U; Arlettaz R; Groneck P; Hammer H; Kössel H; Verellen G; Stock GJ; Lacaze-Masmonteil T; Claris O; Wagner M; Matis J; Gilberg F; J Pediatr; 2002 Jul; 141(1):8-15. PubMed ID: 12091844 [TBL] [Abstract][Full Text] [Related]
13. [Recombinant human erythropoietin in premature infants. Evaluation of a one year experience]. Trentesaux AS; Egreteau L; Santerne B; Morville P Arch Pediatr; 1999 Sep; 6(9):944-51. PubMed ID: 10519027 [TBL] [Abstract][Full Text] [Related]
14. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial. Brown MS; Keith JF Pediatrics; 1999 Aug; 104(2 Pt 1):210-5. PubMed ID: 10428996 [TBL] [Abstract][Full Text] [Related]
15. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627 [TBL] [Abstract][Full Text] [Related]
16. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Franz AR; Pohlandt F Arch Dis Child Fetal Neonatal Ed; 2001 Mar; 84(2):F96-F100. PubMed ID: 11207224 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin and blood transfusion in low-birth weight preterm infants under restrictive transfusion guidelines. Badiee Z; Pourmirzaiee MA; Kelishadi R; Naseri F Saudi Med J; 2006 Jun; 27(6):817-20. PubMed ID: 16758042 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin in the treatment of anemia of prematurity. Chen JY; Wu TS; Chanlai SP Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930 [TBL] [Abstract][Full Text] [Related]
19. Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants. Klipp M; Holzwarth AU; Poeschl JM; Nelle M; Linderkamp O Acta Paediatr; 2007 Feb; 96(2):253-6. PubMed ID: 17429915 [TBL] [Abstract][Full Text] [Related]
20. A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country. Avent M; Cory BJ; Galpin J; Ballot DE; Cooper PA; Sherman G; Davies VA J Trop Pediatr; 2002 Aug; 48(4):227-33. PubMed ID: 12200985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]